✦ LIBER ✦

A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma

✍ Scribed by Janet E. Pope; Nicholas Bellamy; James R. Seibold; Murray Baron; Michael Ellman; Simon Carette; C. Douglas Smith; Ian M. Chalmers; Paul Hong; David O'Hanlon; Elzbieta Kaminska; Janet Markland; John Sibley; Luis Catoggio; Daniel E. Furst

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 81 KB
Volume: 44
Category: Article
ISSN: 0004-3591
DOI: 10.1002/1529-0131(200106)44:6<1351::aid-art227>3.0.co;2-i

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A double-blind randomized controlled tri

A double-blind randomized controlled trial of ketotifen versus placebo in early diffuse scleroderma

✍ Barry L. Gruber; Lee D. Kaufman 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 439 KB 👁 1 views

Methotrexate treatment in juvenile local

Methotrexate treatment in juvenile localized scleroderma: A randomized, double-blind, placebo-controlled trial

✍ Francesco Zulian; Giorgia Martini; Cristina Vallongo; Fabio Vittadello; Fernanda 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 1 views

Steroid-sparing effects of methotrexate

Steroid-sparing effects of methotrexate in systemic lupus erythematosus: A double-blind, randomized, placebo-controlled trial

✍ Fortin, Paul R. ;Abrahamowicz, Michal ;Ferland, Diane ;Lacaille, Diane ;Smith, C 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

Biased assessment of blinding in a rando

Biased assessment of blinding in a randomized placebo-controlled trial of oral methotrexate in chronic progressive multiple sclerosis

✍ D. W. J. Dippel; P. G. Oomes; L. H. Visser 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

Combination of infliximab and methotrexa

Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial

✍ E. William St. Clair; Désirée M. F. M. van der Heijde; Josef S. Smolen; Ravinder 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 1 views

## Abstract ## Objective To compare the benefits of initiating treatment with methotrexate (MTX) and infliximab (anti–tumor necrosis factor α [anti‐TNFα] monoclonal antibody) with those of MTX treatment alone in patients with rheumatoid arthritis (RA) of ≤3 years' duration. ## Methods RA patient

Rapamycin versus methotrexate in early d

Rapamycin versus methotrexate in early diffuse systemic sclerosis: Results from a randomized, single-blind pilot study

✍ Tien-I Karleen Su; Dinesh Khanna; Daniel E. Furst; Gabriel Danovitch; Christina 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

## Abstract ## Objective To assess the safety and efficacy of rapamycin in the treatment of diffuse systemic sclerosis (SSc; scleroderma). ## Methods Eighteen patients with diffuse SSc of ≤5 years duration were randomized to receive rapamycin or methotrexate (MTX) in a single‐blind, 48‐week stud